Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: Characterization and basis of a diagnostic test for MPS

被引:62
作者
Byers, S [1 ]
Rozaklis, T [1 ]
Brumfield, LK [1 ]
Ranieri, E [1 ]
Hopwood, JJ [1 ]
机构
[1] Womens & Childrens Hosp, Dept Chem Pathol, Lysosomal Dis Res Unit, N Adelaide, SA 5006, Australia
基金
英国医学研究理事会;
关键词
mucopolysaccharidoses; urinary glycosaminoglycans; diagnosis; tissue glycosaminoglycans;
D O I
10.1006/mgme.1998.2761
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A combination of anion-exchange chromatography and 30-40% gradient polyacrylamide gel electrophoresis (gradient-PAGE) was used to purify and characterize urinary glycosaminoglycans from various mucopolysaccharidoses (MPS). The urinary glycosaminoglycans from the different MPS displayed distinct patterns on gradient-PAGE and further confirmation of MPS types and subtypes was demonstrated by an electrophoretic shift in the banding pattern after digestion with the appropriate MPS enzyme. Thus each of the MPS accumulates a unique spectrum of glycosaminoglycans with a nonreducing terminal consisting of the substrate specific for the deficient enzyme in that particular MPS disorder. The absolute correlation of the nonreducing terminal structure with a particular MPS and the availability of recombinant lysosomal enzymes provide the means for a rapid and accurate diagnosis of individual MPS. Analysis of tissue glycosaminoglycans in one MPS type (feline MPS VI) indicated a tissue-specific pattern of glycosaminoglycan accumulation. Undegraded glycosaminoglycans had distinct banding patterns on gradient-PAGE and although dermatan sulfate was predominantly excreted in MPS VI urine, some tissues were observed to accumulate predominantly chondroitin sulfate glycosaminoglycans, e.g., bone and kidney. The spectrum of glycosaminoglycans excreted in the urine is therefore most Likely a combination of glycosaminoglycans from various tissues. (C) 1998 Academic Press.
引用
收藏
页码:282 / 290
页数:9
相关论文
共 32 条
[1]   CORRECTION OF HUMAN MUCOPOLYSACCHARIDOSIS TYPE-VI FIBROBLASTS WITH RECOMBINANT N-ACETYLGALACTOSAMINE-4-SULFATASE [J].
ANSON, DS ;
TAYLOR, JA ;
BIELICKI, J ;
HARPER, GS ;
PETERS, C ;
GIBSON, GJ ;
HOPWOOD, JJ .
BIOCHEMICAL JOURNAL, 1992, 284 :789-794
[2]   Turnover of heparan sulfate depends on 2-O-sulfation of uronic acids [J].
Bai, XM ;
Bame, KJ ;
Habuchi, H ;
Kimata, K ;
Esko, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) :23172-23179
[3]  
Bame KJ, 1997, J BIOL CHEM, V272, P2245
[4]   PRODUCTION OF OSTEOCALCIN BY HUMAN-BONE CELLS-INVITRO - EFFECTS OF 1,25(OH)2D3, 24,25(OH)2D3, PARATHYROID-HORMONE, AND GLUCOCORTICOIDS [J].
BERESFORD, JN ;
GALLAGHER, JA ;
POSER, JW ;
RUSSELL, RGG .
METABOLIC BONE DISEASE & RELATED RESEARCH, 1984, 5 (05) :229-234
[5]   Recombinant human sulphamidase: Expression, amplification, purification and characterization [J].
Bielicki, J ;
Hopwood, JJ ;
Melville, EL ;
Anson, DS .
BIOCHEMICAL JOURNAL, 1998, 329 :145-150
[6]   RECOMBINANT HUMAN IDURONATE-2-SULFATASE - CORRECTION OF MUCOPOLYSACCHARIDOSIS-TYPE-II FIBROBLASTS AND CHARACTERIZATION OF THE PURIFIED ENZYME [J].
BIELICKI, J ;
HOPWOOD, JJ ;
WILSON, PJ ;
ANSON, DS .
BIOCHEMICAL JOURNAL, 1993, 289 :241-246
[7]   EXPRESSION PURIFICATION AND CHARACTERIZATION OF RECOMBINANT HUMAN N-ACETYLGALACTOSAMINE-6-SULFATASE [J].
BIELICKI, J ;
FULLER, M ;
GUO, XH ;
MORRIS, GP ;
HOPWOOD, JJ ;
ANSON, DS .
BIOCHEMICAL JOURNAL, 1995, 311 :333-339
[8]   NEW METHOD FOR QUANTITATIVE-DETERMINATION OF URONIC ACIDS [J].
BLUMENKR.N ;
ASBOEHAN.G .
ANALYTICAL BIOCHEMISTRY, 1973, 54 (02) :484-489
[9]   Enzyme replacement therapy in Mucopolysaccharidosis VI: evidence for immune responses and altered efficacy of treatment in animal models [J].
Brooks, DA ;
King, BM ;
Crawley, AC ;
Byers, S ;
Hopwood, JJ .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1997, 1361 (02) :203-216
[10]  
CHEIFETZ S, 1988, J BIOL CHEM, V263, P16984